Thrombin generation test for evaluation of antiplatelet treatment in patients with coronary artery disease after percutaneous coronary intervention

To study the possibility of using thrombin generation tests in platelet-rich and platelet-poor plasma for evaluation of dual antiplatelet therapy efficacy in patients with coronary artery disease (CAD), following percutaneous coronary intervention. Venous blood was analyzed from CAD patients aged 53...

Full description

Bibliographic Details
Published in:	Platelets
Main Authors:	Gelena Berezovskaya, Olga Smirnova, Eduard Malev, Nikita Khromov-Borisov, Elena Klokova, Mikhail Karpenko, Lyudmila Papayan, Nikolay Petrishchev
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2018-02-01
Subjects:	antiplatelet drugs coronary artery disease percutaneous coronary intervention thrombin generation test
Online Access:	http://dx.doi.org/10.1080/09537104.2017.1294680

Similar Items

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
by: Verheugt Freek WA, et al.
Published: (2001-05-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Comparison of the Clinical Efficacy of Bovine Thrombin and Compression Method in Femoral Pseudoaneurysm of Patients Undergoing Percutaneous Coronary Intervention
by: Fariborz Farsad, et al.
Published: (2011-04-01)

Income and antiplatelet adherence following percutaneous coronary intervention
by: Anna R. LaRosa, et al.
Published: (2022-09-01)

Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
by: Jialun Han, et al.
Published: (2023-03-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020-12-01)

Timing of dual antiplatelet therapy in acute coronary syndrome: a problem of coronary artery bypass grafting accessibility for patients
by: T. S. Golovina, et al.
Published: (2020-09-01)

Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients with chronic coronary artery disease (CAD) - current state of knowledge and perspective for further research
by: Hubert Bochenek, et al.
Published: (2025-02-01)

De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?
by: Mattia Galli, et al.
Published: (2022-08-01)

Antiplatelet Strategy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Network Meta‐Analysis
by: Waqas Ullah, et al.
Published: (2024-10-01)

The Impact of Patient Adherence to Dual Antiplatelet Medication Following Percutaneous Coronary Intervention on the Occurrence of Adverse Cardiovascular Events
by: Mansurova JA, et al.
Published: (2024-02-01)

Dual Antiplatelet Therapy in Coronary Artery Disease
by: Raghav Sharma, et al.
Published: (2020-08-01)

Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All‐Cause Mortality in Clinical Trials of Time‐Constrained Dual‐Antiplatelet Therapy After Percutaneous Coronary Intervention
by: John D. McClure, et al.
Published: (2020-08-01)

Duration and clinical outcomes of dual antiplatelet therapy following percutaneous coronary intervention for acute coronary syndrome: A multicentre “real-world practice” registry-based study
by: Carlos E. Vergara-Uzcategui, et al.
Published: (2023-04-01)

Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention
by: Matthias Bossard, et al.
Published: (2017-11-01)

Effect of Dialysis on Antiplatelet Drug Efficacy in Uremic Patients with Coronary Heart Disease
by: Dong-Liang Fu, et al.
Published: (2017-01-01)

Antiplatelet Therapy after Coronary Artery Bypass Graft Surgery – Unevenness of Daily Clinical Practice
by: Ivana Sopek Merkaš, et al.
Published: (2021-01-01)

De-escalation versus standard dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
by: Chen Guo, et al.
Published: (2020-01-01)

Efficiency and safety of various dual antiplatelet therapy strategies in patients undergoing percutaneous coronary intervention due to myocardial infarction
by: S. B. Aksentiev, et al.
Published: (2021-08-01)

Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
by: Ying Shen, et al.
Published: (2015-01-01)

Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
by: Hua Yan, et al.
Published: (2020-06-01)

Abbreviated Versus Standard Dual Antiplatelet Therapy Times After Percutaneous Coronary Intervention in Patients With High Bleeding Risk With Acute Coronary Syndrome: Insights From the SWEDEHEART Registry
by: Anton Håkansson, et al.
Published: (2024-07-01)

Novel antiplatelet targets in the treatment of acute coronary syndromes
by: Fawaz O. Alenazy, et al.
Published: (2021-01-01)

ANTIPLATELET THERAPY IN PROPHILAXY OF NEGATIVE CARDIOVASCULAR EVENTS AFTER CORONARY REVASCULARIZATION. IS THERE A CONSENSUS?
by: Yu. I. Grinschtein, et al.
Published: (2014-06-01)

Antiplatelet Therapy in Acute Coronary Syndrome
by: I. M. Kuzmina, et al.
Published: (2022-01-01)

Dual antiplatelet therapy in patients with acute coronary syndrome. Results of actual clinical practice
by: O. L. Barbarash, et al.
Published: (2018-11-01)

Phenotyping the Use of Cangrelor in Percutaneous Coronary Interventions
by: Nikolaos Pyrpyris, et al.
Published: (2025-03-01)

Trends in dual antiplatelet therapy regimens and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention with drug‐eluting stents: A multicenter real‐world study
by: Preyanate Wilairat, et al.
Published: (2025-03-01)

Risk of Major Bleeding With Potent Antiplatelet Agents After an Acute Coronary Event: A Comparison of Ticagrelor and Clopidogrel in 5116 Consecutive Patients in Clinical Practice
by: Liam Mullen, et al.
Published: (2021-04-01)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Dual antiplatelet therapy for reduction in mortality in patients with acute and chronic coronary syndromes
by: Maciej Lesiak, et al.
Published: (2021-12-01)

Role of Antiplatelet Therapy in Patients with Severe Coronary Artery Disease Undergoing Coronary Artery Endarterectomy within Coronary Artery Bypass Surgery
by: Ilir Balaj, et al.
Published: (2023-03-01)

Efficacy and safety of different dual antiplatelet strategies in patients undergoing percutaneous coronary intervention: A systematic review and network meta‐analysis
by: Yuttana Wongsalap, et al.
Published: (2023-12-01)

Predictors of gastrointestinal bleeding in patients with acute coronary syndrome and the optimal duration of dual antiplatelet therapy
by: Yanyu Wang, et al.
Published: (2024-03-01)

Antiplatelet therapy in elderly patients with acute coronary syndrome: Between scientific evidence and future perspectives
by: Francesco Barillà, et al.
Published: (2018-06-01)

Abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
by: Hamidreza Soleimani, et al.
Published: (2025-04-01)

Early discontinuation of dual antiplatelet therapy via acetylsalicylic acid cessation in patients with acute coronary syndrome undergoing percutaneous coronary interventions to reduce the bleeding risk
by: O. V. Averkov
Published: (2021-02-01)

Anticoagulant and antiplatelet treatment effects on the incidence of major cardiovascular events in patients with coronary artery ectasia: An updated systematic review
by: Afshin Amirpour, et al.
Published: (2024-07-01)

The efficacy and safety of CYP2C19 genotype-guided antiplatelet therapy compared with conventional antiplatelet therapy in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
by: Si-Qi Lyu, et al.
Published: (2020-11-01)